Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling by Sheth, Chirag C et al.
  Circulating polymorphonuclear (PMN) cells play a 
central role in the control mechanism preventing the 
spread of infection in the host. Fungal cells are recog-
nized and engulfed by these leukocytes, thereby reducing 
the number of infectious cells in the body [9,10]. Contact 
between pathogen and PMN also leads to the further acti-
vation of the innate immune system via the production of 
cytokines and chemotactic factors [11]. Cytokines acti-
vate PMNs and other cells in the immediate environment, 
while chemokine production generates a diffusible leuko-
cyte attraction gradient, drawing increasing numbers of 
immune cells to the site of infection [12]. Stimulated neu-
trophils activate a programmed antimicrobial response, 
known as the respiratory burst, leading to the release of 
signifi  cant quantities of toxic oxygen and nitrogen free 
radicals into the local environment, which can also cause 
infl  ammation and damage to the cellular integrity of local 
tissue [10,13]. The importance of PMNs in host defense 
is highlighted in studies showing that neutropenic patients 
[14,15] and those with peroxidase-defi  ciency are found 
to be highly susceptible to invasive   C. albicans   infections 
[16,17]. 
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    Introduction 
  C. albicans   is ordinarily found as a commensal yeast col-
onizing the human gastrointestinal tract. It is, however, 
able to invade and cause deep-seated infections in indi-
viduals with compromised host defenses arising from 
trauma, the administration of immunosuppressive agents, 
a variety of disease and association with a number of 
genetic mutations that affect immune recognition [1  –  3]. 
Invasive, disseminated candidiasis for a range of   Candida  
species is associated with mortality rates of 30  –  60% with 
  C. albicans   being the most common and pathogenic of the 
species known to cause invasive disease [4  –  8]. Many of 
the virulence traits of this fungus are related to the proper-
ties of highly glycosylated proteins in the outer wall and 
secretome of the organism. 
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  The cell wall of the opportunistic human fungal pathogen,   Candida albicans   is a 
complex, layered network of rigid structural polysaccharides composed of  β -glucans and 
chitin that is covered with a fi  brillar matrix of highly glycosylated mannoproteins. Poly-
morphonuclear cells (PMNs, neutrophils) are the most prevalent circulating phagocytic 
leukocyte in peripheral blood and they are pivotal in the clearance of invading fungal 
cells from tissues. The importance of cell-wall mannans for the recognition and uptake 
of   C. albicans   by human PMNs was therefore investigated.   N-   and   O- glycosylation-
defi  cient mutants were attenuated in binding and phagocytosis by PMNs and this was 
associated with reduced killing of   C. albicans   yeast cells. No differences were found 
in the production of the respiratory burst enzyme myeloperoxidase (MPO) and the 
neutrophil chemokine IL-8 in PMNs exposed to control and glycosylation-defi  cient 
  C. albicans   strains. Thus, the signifi  cant decrease in killing of glycan-defi  cient   C. albicans  
strains by PMNs is a consequence of a marked reduction in phagocytosis rather than 
changes in the release of infl  ammatory mediators by PMNs.   
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  The primary point of interaction and recognition 
between the host immune system and   C. albicans   occurs 
at the interface of the outer cell wall of the fungus and 
the receptor proteins in the leukocyte membranes. There-
fore the outer fungal cell wall has an important role to 
play in defi  ning the outcomes of such exchanges. The 
composition and structure of fungal cell wall is highly 
regulated, but the major components in   C. albicans   con-
sist of a rigid, inner skeletal layer of chitin and inter-
linked   β   1,3- and   β   1,6- glucan to which a fl  exible 
mannoprotein matrix is attached covalently to   β -glucans 
and chitin predominantly via glycosylphosphatidyinositol 
(GPI) anchors [11,18,19]. Protein mannosylation occurs 
in two major forms,   N-   and   O-  linked, and many of the key 
glycosyl transferases have been highly studied in the 
model yeast   Saccharomyces cerevisiae   [20  –  22] and in   C. 
albicans   [23 – 26]. 
  N-  linked mannans are characterized by a conserved 
[mannose]  8  [ N -acetylglucosamine] 2   core structure (num-
bers in subscript indicating repeating units), appended to more 
structurally diverse outer chains (Fig. 1). In   C. albicans  
the outer chains consist of a   α  -(1,6)- mannose backbone 
to which are attached side chains consisting of   α -(1,2)- 
  β  -(1,2)- and   α  -(1,3)- linked mannose and phosphoman-
nose branches [27].   C. albicans    N-  linked and   O -linked 
mannans have been shown to be important for adhesion 
and other virulence traits and for the induction of the 
innate immune response in the host, including the produc-
tion of pro-infl  ammatory cytokines and anti-mannan anti-
bodies via the stimulation of a number of immune cell 
types  [28 – 30]. 
  C. albicans O  -linked mannans are simpler structures, 
consisting of a linear (unbranched) chain of mannose 
residues, predominantly   α  -(1,2)-linked (Fig. 1) [26,31]. 
  O-  linked mannans are attached to cell wall proteins via 
serine or threonine residues that are frequently clustered in 
domains that correspond to the rod-like stems of glycopro-
teins that present a globular N terminus towards the extra-
cellular face of the wall [22].   C. albicans   strains defi  cient 
in   O  -mannan synthesis were found to be attenuated in 
virulence [26,32] and adhesion to epithelial cells [33,34], 
displayed altered cytokine stimulation profi  les and were 
less sensitive to killing by neutrophils [35]. 
  To investigate the importance of   C. albicans   cell wall 
  N-   and   O-  linked glycosylation on the fungus-human 
PMN interaction, we used a series of   C. albicans   strains 
defective in different cell wall glycosylation components. 
The host-fungus interaction was characterized by quanti-
fying the proportions of   C. albicans   bound or engulfed 
by the PMNs, the percentage of fungal cells killed fol-
lowing co-incubation, and PMN activation by measure-
ment of supernatant myeloperoxidase and IL-8. 
Additionally, the sensitivity of   C. albicans   glycosylation-
defective strains to PMN-derived anti-microbial com-
pounds was investigated.     
  Materials and methods   
  Strains, media and culture conditions 
  All strains used in this study are listed in Table 1. Strains 
were maintained as frozen glycerol stocks and grown in 
Sabouraud broth (1% mycological peptone, 4% glucose) 
for 16 h at 30  °  C with shaking at 200 rpm. For the prep-
aration of co-incubation inocula, above cultures were 
diluted 1:100 into 50 ml fresh sterile Sabouraud broth 
and incubated at 30  °  C with shaking at 200 rpm until the 
OD  600   reached 0.6. The cells were then washed three 
times in sterile phosphate-buffered saline (PBS, pH 7.5), 
and resuspended to a fi  nal concentration of 1      10 8   cells/
ml in PBS. Prior to use, an aliquot of the required num-
ber of cells was labeled with 0.1 mg/ml fl  uorescein 5-iso-
thiocyanate (F2502, Sigma-Aldrich, UK) in 0.05 M 
carbonate-bicarbonate buffer (C3041, Sigma-Aldrich, 
UK), for 15 min at room temperature with continual agi-
tation. Cells were then washed three times with sterile 
PBS and used immediately in experiments with   C. albi-
cans   cells.       
Table 1 Candida albicans strains used in this study.
Strain description Genotype Strain # Reference
CAI-4  CIp10 Δura3::imm434/Δ ura3::imm434, RPS1/rps1Δ::CIp10 NGY152 [24]
och1Δ As NGY152 but och1Δ::hisG/och1Δ::hisG, RPS1/rps1Δ::CIp10 NGY357 [23]
och1Δ  CIp10-OCH1 As NGY152 but och1Δ::hisG/och1Δ::hisG, RPS1/rps1Δ::CIp10-OCH1 NGY358 [23]
pmr1Δ As NGY152 but pmr1Δ::hisG/pmr1Δ::hisG, RPS1/rps1Δ::CIp10 NGY355 [38]
pmr1Δ + CIp10-PMR1 As NGY152 but pmr1Δ::hisG/pmr1Δ::hisG, RPS1/rps1Δ::CIp10-PMR1 NGY356 [38]
mnt1Δ/mnt2Δ As NGY152 but mnt1-mnt2Δ::hisG/mnt1-mnt2Δ::hisG-URA3-hisG NGY111 [26]
mnt1Δ/mnt2Δ + CIp10-MNT1 As NGY152 but mnt1-mnt2Δ::hisG/mnt1-mnt2Δ::hisG, RPS1/rps1Δ::CIp10-MNT1 NGY335 [26]
mnn4Δ As NGY152 but mnn4Δ::hisG/mnn4Δ::hisG, RPS10::URA3 CDH15 [24]
mnn4Δ + CIp10-MNN4n As NGY152 but mnn4Δ::hisG/mnn4Δ::hisG, RPS10::CIp10-MNN4-URA3] n CDH13 [24]
A9 (Serotype B) – — [39]© 2011 ISHAM, Medical Mycology, 49, 513–524
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  Phagocytosis assay 
  A sample of 3      10 6   washed FITC-labeled   C. albicans   cells 
were co-incubated with 1      10 6   freshly isolated, anti-CD13.
PE-Cy5 labeled human PMNs (effector: target ratio 3:1), and 
co-incubated in RPMI-1640 medium supplemented with 
10% donor  ’  s own serum for 30 min at 37  °  C with continuous 
shaking. Cells were harvested by centrifugation at 500   g , 
resuspended and fi  xed in 500   μ  l ice-cold PBS with 40 mM 
EDTA and 1% (v/v) paraformaldehyde, and stored on ice.      
  Killing assay 
  Samples of 3      10 6   FITC-labeled   C. albicans   cells were 
co-incubated with 1      10 6   freshly isolated, anti-CD13.
PE-Cy5 labeled human PMNs (effector: target ratio 3:1), 
and co-incubated in RPMI-1640 medium supplemented 
with 10% donor serum for 150 min at 37  °  C with con-
tinuous shaking. No hypha formation was observed inside 
the neutrophils by this time, thus no killing of neutrophils 
occurred due to hypha formation within the phagolyso-
some. Fungal cells were harvested by centrifugation at 
1500   g  , and the supernatant discarded. Hypotonic lysis of 
the PMNs (pure water, 1 min at room temperature) was 
followed by three washes in sterile PBS. Finally the 
released   C. albicans   cells were resuspended in 1% para-
formaldehyde in PBS, containing 4   μ g/ml  propidium 
iodide (PI). The percentages of dead cells with PI-stained 
nuclei were quantifi   ed by fl  uorescence  microscopy. A 
minimum of 3 groups of 100 cells were counted for each 
  Preparation of human PMNs 
  Human PMNs were isolated from freshly isolated, EDTA-
anticoagulated peripheral venous blood of healthy human 
volunteers [36]. Briefl  y, whole blood was diluted 1:2 in 
sterile PBS and 35 ml aliquots dispensed into 50 ml poly-
propylene tubes. Gently, 15 ml of Ficoll-Paque PLUS 
(17-1440-02, GE Healthcare, UK) was layered under the 
whole blood by sterile Pasteur pipette. Tubes were cen-
trifuged at 400 g for 20 min at room temperature. The 
overlying plasma layer was carefully aspirated and cen-
trifuged at 1500   g   to generate platelet-poor plasma (PPP). 
The lymphocyte and Ficoll-Paque PLUS layers were 
aspirated and discarded. The pellet, containing erythro-
cytes and PMNs was lysed using RBC lysis buffer 
(420301, Biolegend, USA) according to the manufacturer ’ s 
instructions. The resulting PMN pellet was washed twice 
in sterile PBS at room temperature, with centrifugation at 
400   g   and fi  nally resuspended in pre-warmed RPMI-1640 
medium supplemented with 10% donor  ’  s PPP. Neutro-
phils were examined by light microscopy and cell viabil-
ity was established as     98% by Trypan Blue dye 
exclusion [37]. All tests were completed within 5 h of 
PMN isolation. 
  As required aliquots of 1      10 6   PMNs were labeled 
with anti-CD13.PE-Cy5 (A07763, Beckman Coulter, USA) 
according to the manufacturer  ’  s instructions for 30 min 
at room temperature in the dark. After two washes in ster-
ile PBS with centrifugation at 400 g the cells were ready 
for use.     
   Fig.  1   The structure of   N  -mannan (including phosphomannan) and   O  -linked mannan of   C. albicans  . The different glycosyl linkages are shown as different 
colored hexagons and the point of truncation of the various mutants used in this study is indicated by arrows. The extent of truncation of the   N -mannan 
  α  -1,6 mannose backbone in the   pmr1    Δ   mutant is not fi  xed, and does not remove all of the outer chains, as in the   och1  Δ   mutant.  See  references  [23 – 26].  © 2011 ISHAM, Medical Mycology, 49, 513–524
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Fig. 2   FACS assay for binding and phagocytosis and validation confocal fl  uorescence microscopy. Test co-incubation samples of C. albicans and 
PMNs (ratio 3:1) were analyzed by FACS (SI Materials and Methods – online only). (A) A scatter-graph of PMN associated-C. albicans cells plotted 
as a function of FITC versus CFW fl  uorescence intensities. Two sub-populations of fungal cells are resolved, corresponding to engulfed (quadrant Q1-2) 
and adhered (quadrant Q2-2) C. albicans cells. PMNs not associated with C. albicans cells were excluded from the analysis by FACS software.
(B) Confocal fl  uorescence microscopic images of representative sorted cells from quadrants Q1-2 and Q2-2 validating the FACS analysis and gating 
strategy. Engulfed, FITC-labeled C. albicans cells are visible in the upper-left quadrant, whilst PMNs with adhered fungal cells stained with the cell-
wall specifi  c dye CFW are shown in the upper-right quadrant. PMNs not associated with C. albicans cells were sorted and visualized (lower-left quadrant), 
thereby validating the selection of the PMN-specifi  c antibody.
strain and the experiment repeated for a total of six inde-
pendent biological replicates. Controls in the absence of 
PMNs showed 0% killing, therefore all killing was 
ascribed to the activities of the PMNs. For fl  uorescence 
images on PMNs with attached and phagocytosed   C. albi-
cans   cells a Zeiss Axioplan 2 microscope (63      magni-
fi  cation) with the Hamanatsu C4742-95 digital camera 
was used and images were analyzed with Openlab 
software V4.0.4.     
  Flow cytometry analysis of phagocytosis 
  Flow cytometry analysis of the samples was carried out 
using a LSRII fl   ow cytometer (Becton Dickinson, 
Heidelberg, Germany), with computer-assisted evalua-
tion of the generated data by FACS Diva software (Bec-
ton Dickinson, Heidelberg, Germany). The fungal cell 
wall dye Calcofl  uor White (CFW) was added to a fi  nal 
concentration of 10   μ  g/ml immediately prior to fl  ow 
cytometry, allowing distinction between bound and 
engulfed   C. albicans   cells. In principle, internalized 
fungal cells are encapsulated by the intact cell mem-
brane of the PMN, thereby preventing their staining by 
CFW. Free, suspended   C. albicans   cells or cells adhered 
to the outside of the neutrophil are stained by the 
fl   uorophore and were detected via the Pacifi  c  Blue 
channel.   
  Cytokine and chemokine assays for PMN activation 
 Supernatants collected following co-incubation of PMNs 
and   C. albicans   cells were assayed for markers of PMN 
activation. Simultaneous screening of 36 cytokines, 
chemokines and other secretory proteins was carried out 
using a human cytokine profi  ler kit (R&D Systems UK, 
Cat# ARY005) according to the manufacturer  ’  s instruc-
tions. The cytokine profi   ler data, in addition to con-
ventional sandwich ELISA-based analysis confi  rmed 
evidence from other groups showing that activated neu-
trophils release the respiratory burst associated proteins 
myeloperoxidase and lactotransferrin (LTF) into the 
environment when stimulated [10]. IL-8 secretion was 
found to be a consistent marker of PMN activation in 
this study. Quantifi  cation of IL-8 and MPO markers was 
carried out according to the manufacturer  ’  s instructions 
using commercially available sandwich ELISA-based 
assays (IL-8   –   R&D Systems, Cat# DY208, MPO   –   
Calbiochem, Cat# 475918).       
  Results   
  Flow cytometric analysis of attachment and phagocytosis 
of C. albicans by PMN cells 
  To characterize the effects of changing glycosylation status 
upon host:fungus interaction, we challenged purifi  ed © 2011 ISHAM, Medical Mycology, 49, 513–524
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human PMNs with a range of glycosylation-defective 
strains of   C. albicans  . Incubations were carried out for 
30 min to evaluate glycosylation effects on adherence and 
phagocytosis. In the following description, we take   ‘  asso-
ciation  ’   to mean all   Candida   cells co-sorting with PMNs 
following the incubation period (including adhered and 
phagocytosed  subsets),  whilst   ‘ attached ’   or   ‘ adhered ’  
cells refer to subsets of the associated cells bound to the 
PMN cell surface, undergoing phagocytosis. Various sub-
sets of   C. albicans   yeast cells that were interacting with 
PMNs were distinguished in the analysis. An   ‘  association  ’   
indicates   C. albicans   cells that co-sort with PMNs and 
includes adhered and phagocytosed yeast cells. Yeast 
cells  that  were   ‘ attached ’   or   ‘ adhered ’   refers  to  subsets 
of associated cells that were bound to the PMN cell sur-
face but were not phagocytosed while   ‘  engulfed  ’   refers 
to   C. albicans   cells that had been phagocytosed. The 
strains used in this study are shown in Table 1 and in 
Fig. 1. Briefl  y, the   och1    Δ   strain lacks the branched, outer 
part of the   N-  glycan structure [23], the   pmr1  Δ   strain  has 
a truncated   O-  glycan and   N-  glycan structure [38], the 
  mnt1  Δ   /mnt2    Δ   strain contains only a single   O -linked 
mannose residue [26] and the   mnn4  Δ   strain  lacks  cell 
wall phosphomannan including the acid-labile   β -1,2 
mannan fraction [24].   C. albicans   serotype B strain A9 
differs from the serotype A strains in being defi  cient in 
  β -1,2 mannose in the acid stable component of the  N -linked 
mannan [39]. Serotype A strains include the SC5314 strain 
that is the genetic background for all the mutants used in 
this study. 
  Evaluation of FACS assay that measured the binding 
and uptake of   C. albicans   by neutrophils was also vali-
dated by fl  uorescence microscopy. Two sub-populations 
of   C. albicans   cells could be distinguished using FACS 
(Fig. 2A).   C. albicans   cells association with PMNs was 
expressed as a function of FITC fl  uorescence versus CFW 
fl  uorescence (measured on the Pacifi  c Blue channel).   C. 
albicans   cells in quadrant Q1-2 (FITC    , CFW-) represent 
engulfed cells whilst those in quadrant Q2-2 (FITC   , 
CFW     ) represent cells attached to the PMN surface (Fig. 
2A). Engulfed and adhered (non-engulfed) cells from each 
of the sub-populations were also visualized by fl  uore-
scence microscopy (Fig. 2B) and corresponded to cells 
within the various FACS quadrants. Empty PMNs were 
excluded from the plot in Fig. 2A, however they were 
visualized by fl   uorescence microscopy demonstrating 
positive   α  -CD13 antibody selection of the target immune 
cell type (Fig. 2B). These data together demonstrate the 
robustness of the FACS technique in characterizing 
adherence and phagocytosis of   C. albicans   cells by 
human PMNs. 
  Flow cytometry was used to investigate the adherence 
and engulfment of   C. albicans   cells by human PMN 
following co-incubation for 30 min at 37  °  C. The gating 
strategy employed to analyze the fl  ow cytometry data is 
described in the Online Supplementary Information (SI): 
Materials and Methods. After 30 min co-incubation, 
approximately 36      2% (mean      SE   –   and in all cases 
below) of the control   C. albicans   cells were co-sorted 
with PMNs (Fig. 3). The   mnt1  Δ   /mnt2  Δ   and   C. albicans  
Serotype B strains, had reduced association with PMN 
cells (23      3 and 27      3%, [  P       0.01 and   P       0.05] 
respectively) suggesting that   O  -mannan or   β   1,2 linked 
mannan was implicated in PMN recognition and binding. 
PMN cells were attenuated in their ability to engulf   N-   and 
  O- glycosylation-defective   C. albicans   strains (Fig. 3). 
Analysis of the fl  ow cytometry data showed that 62      2% 
of the cells of the CAI-4      CIp10 control strain bound 
to PMNs were engulfed within 30 min co-incubation. 
In contrast, only 33      6% of   och1  Δ ,  40      3% of   pmr1  Δ , 
and 38      4% of   mnt1  Δ  /mnt2  Δ   cells  were  engulfed 
(  P       0.01) (Fig. 3). Consequently, the reduced engulfment 
of mutant strains resulted in an accumulation of attached 
(adhered), non-engulfed   C. albicans   cells at the PMN 
surface. In turn the percentage of adhered   C. albicans  
cells rose from 38      2% in the control (CAI-4      CIp10) 
strain to 64      6% (  och1  Δ ),  60      3% (  pmr1  Δ ),  and 
62      4% (  mnt1  Δ   /mnt2  Δ )  for  the  glycosylation-defective 
mutants respectively. Complementation of the deleted 
genes in all cases reverted the ratio of engulfed:adhered 
  C. albicans   to that resembling the control strain. The 
  mnn4  Δ   strain  lacking   N-  linked cell wall phosphomannan 
exhibited a relatively minor reduction in engulfment 
(53      3%) in comparison to the other strains tested, 
although this was still signifi  cantly less than the control 
strain (Fig. 3). Likewise, the percentage of   mnn4  Δ   cells 
adhered to the PMNs increased slightly but signifi  cantly 
with respect to the control strain (up to 46      3%). Com-
plementation of the mutant with the wild type gene 
restored the control profi   le of engulfed and adhered   
C. albicans   cells to control levels although the   mnn4  Δ  
reintegrant strain, which contained multiple   MNN4   alleles 
was more readily engulfed than the wild type (Fig. 3). 
The   C. albicans   Serotype B strain that lacked acid-stable 
  β   1,2-linked mannose residues in the   N- glycan  outer 
chain had little difference in adherence and uptake into 
neutrophils (Fig. 3). Therefore, the cell wall glycosyla-
tion status (alterations in   N-   and  O -linked  glycosylation 
and phosphomannosylation) but not changes in the   β   1,2 
mannose content, reduced the engulfment of adherent 
fungal cells by human PMNs.      
  The effect of glycosylation status of   C. albicans   phago-
cytosis by purifi   ed anti CD13-PE-CY5-labeled human 
PMNs was validated independently by microscopy. PMNs 
were co-incubated with FITC-labeled   C. albicans   glyco-
sylation mutants. After fi  xation, the   C. albicans   cell wall © 2011 ISHAM, Medical Mycology, 49, 513–524
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dye, Calcofl  uor White, was added immediately prior to 
microscopy to distinguish between   C. albicans   cells 
adhered to the PMN surface and those that had been inter-
nalized through phagocytosis. Prolonged exposure to the 
fi  xation solution (1% paraformaldehyde, 40 mM EDTA) 
resulted in non-specifi  c staining of the PMN nuclei by Cal-
cofl  uor White, presumably due to increased permeability 
of the cell membrane. Therefore, to ensure that any non-
specifi   c staining did not interfere with FACS analysis, 
samples were analyzed minutes after fi  xation when no non-
specifi  c CFW staining was observed. The majority of the 
CAI4-CIp10 (wild type control strain) cells associated with 
PMNs fl  uoresced only under the FITC fi  lter, suggesting 
that they had been phagocytosed and were not exposed on 
the PMN surface. However, the   C. albicans   strains that 
were defective in cell wall glycosylation fl  uoresced under 
both the FITC and Pacifi  c Blue channels, indicating that 
the majority of   C. albicans   cells had adhered to the PMN 
surface, but that the PMNs were unable to phagocytose the 
cells. Reintroduction of a single copy of the desired gene 
again restored the ability of the PMNs to phagocytose the 
  C. albicans   strain to almost wild type levels, confi  rming 
that the glycosylation status of   C. albicans   is important for 
phagocytosis (Fig. 4).     
  Comparison of killing of C. albicans glycosylation-defective 
mutant strains by PMN cells 
  Next we assessed whether changes in the fungal cell-wall 
glycosylation status altered susceptibility to killing by 
PMNs. The sensitivity of   C. albicans   cell-wall glycosyla-
tion-defi  cient strains to PMN-mediated damage was inves-
tigated using phagocytosis-dependent and phagocytosis-
independent killing assays. For the former,   C  .  albicans  
cells were subjected to an extended co-incubation period 
of 150 min to assay the killing effi  ciency of PMNs with 
respect to fungal glycosylation status. Analysis of pro-
pidium iodide stained fungal cells showed that 66      4% 
of the control fungal cells were killed in this period 
(Fig. 4). Glycosylation defects reduced the proportion of 
fungal cells killed by PMNs. Only 46      4% of   och1  Δ  ,  
51      4% of   pmr1  Δ ,  41      4 % of   mnt1  Δ   /mnt2  Δ   and 
46      4% of   mnn4    Δ   cells were killed (  P       0.05 in all 
cases, except for   pmr1  Δ   strain,  where   P       0.15) (Fig. 4). 
Complementation of the deleted genes restored some 
measure of susceptibility to killing, although this was not 
always to control levels. A positive correlation existed 
between the percentage of dead   C. albicans   cells and the 
percentage of cells that had been engulfed (Pearson  ’  s cor-
relation coeffi  cient, [r]      0.71).   
Fig. 3  Analysis of binding and phagocytosis of C. albicans glycosylation-defi   cient mutant strains by FACS. Bars indicate the percentage of 
C. albicans cells associated with, bound to, or engulfed by human PMNs following 30 min of co-incubation at 37°C. The solid bars represent the 
percentage of C. albicans yeast cells (as a proportion of the total C. albicans cells counted) co-sorting with PMNs. This refl  ects differences in the 
recognition and binding of the various C. albicans strains by PMNs. Grey bars show the percentage of C. albicans yeast cells adhered to versus those 
engulfed by PMNs (subsets of the C. albicans yeast cells co-sorted with PMNs) and represent a measure of the relative ability of PMNs to phagocytose 
the C. albicans yeast cells. The open bars represent the proportion of associated cells that had been phagocytosed at this time point. Plotted values are 
the mean  standard error of triplicate experi  ments using PMNs from six independent donors. Statistical signifi  cance was carried out by a student’s 
t-test (vs the value for the control strain in each case): **P  0.05.© 2011 ISHAM, Medical Mycology, 49, 513–524
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  Effects of glycosylation upon phagocytosis-independent 
killing of C. albicans by PMNs 
  PMNs can kill   C. albicans   by several mechanisms and 
reciprocally the ability of   C. albicans   to reduce PMN 
viability may be affected by the presence of other micro-
organisms and antigens. PMNs can ingest and digest 
pathogens but also release of large quantities of enzymes 
and toxic free-radicals into the environment, causing 
damage and death to non-ingested pathogens in the vicin-
ity of the immune cells [10]. Here we investigated the 
viability of PMNs in the presence and absence of bacte-
rial cells or bacterial LPS and the effect of PMN super-
natants on the viability of   C. albicans . 
  First, we investigated the effect of 30 min co-incubation 
with LPS, two bacterial and one   C. albicans   glycosylation-
defi  cient strain on PMN viability by Trypan Blue exclusion. 
Stimulation by LPS, heat-killed   Pseudomonas aeruginosa  
and heat-killed   Escherichia coli   resulted in a higher propor-
tion of dead PMNs (58      10%, 40      11% and 45      5% 
respectively), as compared to pre-stimulation with any of the 
  C. albicans   strains CAI-4 (28      3%),   pmr1  Δ   (29      1%) and 
  pmr1  Δ         PMR1   (37      7%) respectively (SI Fig. S2   –   online 
only). Therefore, more PMNs were killed following co-
incubation with bacterial cells and LPS as compared to fol-
lowing co-incubation with the   C. albicans   strains tested. 
  Next, we investigated whether PMNs exposure to wild-
type and   C. albicans   mutant strains would affect the com-
position and quantity of microbicidal compounds released 
into the cell-culture supernatant (Supplementary Materials 
and Methods: Supplementary method 2   –   online only). The 
results in SI Table S1     indicate that following the 30 min 
pre-incubation period, fungal cells generally elicited higher 
levels (20  –  25 ng/ml) of MPO production by PMNs as com-
pared to LPS (9      1 ng/ml),   P. aeruginosa   (13      2 ng/ml) 
and   E. coli   (12      4 ng/ml). IL-8 induction was similar 
irrespective of the stimulus (  ∼ 16      2 ng/ml) Fig. 5). The 
effi  cacy of these cell-culture supernatants to kill   C. albi-
cans   was characterized by co-incubation with fungal cells 
over 150 min.  
 The percentage of dead  C. albicans  cells following 150 min 
incubation with cell culture supernatants from pre-stimu-
lated PMNs showed no statistically signifi  cant difference, with 
Fig. 4  Glycosylation status of the C. albicans cell wall is important for phagocytosis by neutrophils. FITC-labeled C. albicans cells (3  106) were 
incubated with purifi  ed anti-CD13-PE-Cy5 labeled neutrophils (1  106) at 37°C for 30 minutes in RPMI medium supplemented with 10% donor’s 
plasma. Cells were fi   xed with 1% paraformaldehyde and 40mM EDTA and 10 μg/ml Calcofl   uor White added 1 minute prior to microscopy. 
(A) CAI4  CIp10, (B) Serotype B, (C) (i) Δmnn4 (ii) Δmnn4  MNN4, (D) (i) Δoch1 (ii) Δoch1  OCH1. Note in (D) (i) that the FITC-stained yeast 
cells have a blue Calcofl  uor White-stained halo indicating they are on the PMN surface, while in (D) (ii) the FITC-stained cells are phagocytosed and 
do not stain with Calcofl  uor White. Scale bar represents 10 μm.© 2011 ISHAM, Medical Mycology, 49, 513–524
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respect to the pre-stimulant. All the   C. albicans   strains 
tested in this assay were equally sensitive to supernatant 
from pre-stimulated PMNs (42      8% killed   C. albicans  
cells) (SI Fig. S2   –   online only). Supernatant concentra-
tions of MPO and IL-8 did not change during co-incubation 
with fungal cells (SI Table S1   –   online only). Yeast strains 
of the   pmr1    Δ   mutant showed similar sensitivity to cell 
damaging agents released by activated neutrophils when 
compared to their wildtype control.     
  PMN stimulation by cytokine and chemokine analysis 
  Activated PMNs are able to secrete a variety of cytokines 
and chemokines into their immediate environment, result-
ing in autoinduction and the generation of chemoattrac-
tant gradients. The activation of PMNs in response to 
stimulation by glycosylation-defective   C. albicans   strains 
was characterized by quantifying supernatant levels of 
secreted markers of activation. Initial testing using the 
R&D Systems proteome profi  ler cytokine assay kit (R&D 
Systems UK, catalog # ARY005), which has been effec-
tive in the analysis of cytokine release from monocytes 
[40] and T-cells [41], identifi  ed IL-8, MPO and LTF as 
being upregulated. Supernatant levels of IL-8, IL13, mac-
rophage migration inhibitory factor (MIF), macrophage 
infl  ammatory  protein-1  α   (MIP1 α  ), granulocyte colony 
stimulating factor (G-CSF), granulocyte-macrophage 
colony stimulating factor (GM-CSF) and complement 
component C5a, were found to be elevated with respect 
to the control, with C5a, IL-8 and MIF among the highest 
induced (not shown). 
  PMN cell activation was characterized by investigating 
the production of myeloperoxidase (MPO) and the cytokine 
IL-8 (CXCL8) in cell culture supernatant following 30 min 
co-incubation with   C. albicans   strains (LTF was not stud-
ied in detail as similar to MPO it is a marker of the respi-
ratory burst). MPO catalyses the formation of hypochlorous 
acid and other toxic reactive oxidants following neutrophil 
activation, and has been shown to play a key role in the 
control of   C. albicans   infection by PMNs [17,42,43]. IL-8 
is produced by a variety of human immune cells including 
neutrophils, and is a potent stimulant of PMN cells [44,45]. 
There was a basal level of MPO production (8      2 ng/ml) 
following PMN purifi  cation, as evidenced by the T      0 
sample (Fig. 6).      
  Analysis of the cell culture supernatant of PMNs that 
had not been exposed to   C. albicans   resulted in a basal level 
of MPO production (16      2 ng/ml). Co-incubation with 
  C. albicans   resulted in increased levels of MPO with a 
mean of 22      5 ng/ml. There was no signifi  cant difference 
in the induction of MPO production between the glycosylation-
defi  cient and parent strains of   C. albicans   tested (Fig. 6). 
Following co-incubation of PMNs with   C. albicans   super-
natants were assayed and found to contain higher levels of 
IL-8 (an average of 27      11 ng/ml across the strains tested). 
However, no signifi  cant differences in IL-8 production were 
found between the mutant and wildtype strains that were 
tested. Thus PMNs upon exposure to   C. albicans   produced 
MPO and IL-8, but this was not dependent on the glycosy-
lation status of the cell wall.     
  Discussion 
  C. albicans   is the most common cause of invasive noso-
comial disease [46,47]. Increased mortality rates and fail-
ure to clear infection in neutropenic patients [48] and 
those with genetic abnormalities related to neutrophil 
function [49] highlight the critical role played by PMNs 
in controlling the growth and spread of pathogens. In this 
study we examined the effects of   C. albicans   cell wall 
glycosylation on the binding and phagocytosis by PMNs. 
We show that   O-  glycosylation plays a role in the 
initial association between PMNs and   Candida   as  
O -glycan-defi  ciency resulted in signifi  cantly fewer cells 
associated with PMNs as compared to control and   N- 
glycosylation mutant strains. In addition, loss of cell wall 
  N-   and   O-  glycans results in a reduced capacity of PMNs 
to phagocytose fungal cells. PMNs were able to phago-
cytose signifi   cantly fewer   och1  Δ ,   pmr1  Δ ,  and   mnt1  Δ   /
mnt2    Δ   mutant cells as compared to the control strain. 
Binding of these mutants was not abolished however, 
Fig. 5  C. albicans killing assay. Bars show the percentage of the tested 
C. albicans killed following 150 min co-incubation with PMNs at 37°C. 
Following incubation, PMNs were lysed by hypotonic shock. The 
remaining C. albicans were washed and stained with 4 μg/ml propidium 
iodide to stain exposed nucleic acid in dead and terminally damaged cells. 
A minimum of 100 cells of each strain were counted and the percentage 
of dead (PI) cells calculated. Plotted values are the mean  standard 
error of six experiments with independent donors, in which each 
combination was tested in triplicate. Statistical signifi  cance was carried 
out by a student’s t-test (vs the value for the control strain in each case): 
**P  0.05.© 2011 ISHAM, Medical Mycology, 49, 513–524
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implying that residual cell wall components such as 
  β  -glucans also play a role in uptake by PMNs. In such 
strains a corresponding increase in the percentage of 
adhered cells was found refl  ecting the disruption of the 
engulfment process leading to an accumulation of  C. albicans  
on the PMN cell surface. The data suggest that recogni-
tion and uptake of fungal cells by PMNs is a two-step 
process and suggests that independent receptor-ligand 
interaction mediated by cell surface mannans may be 
required, for each stage to be successfully completed. 
This is in keeping with previous observations for the 
phagocytosis of apoptotic cells where a two step process 
for successful phagocytosis has been proposed [36]. 
  Previous work from our laboratory has shown that loss 
of cell wall phosphomannan had little impact upon   
C. albicans   virulence in a murine model [24]. This study 
advances the body of information relating to the role of 
phosphomannan at the fungal cell surface, showing that 
mutants lacking the epitope are slightly attenuated in 
their phagocytosis by PMNs. The decrease in phagocy-
tosis was observed to be much greater in   N-   and   O- 
glycan-defi  cient mutants as compared to the   mnn4  Δ   strain 
indicating the relatively minor role of phosphomannan as 
compared to glycosylation, in the recognition, attachment 
and phagocytosis by neutrophils. Therefore non-phago-
cytosis-dependent interactions and adhesion to PMNs is 
unlikely to be due to charge interactions with PMN in 
the   C. albicans   cell wall. This highlights important 
differences in the phagocytosis of   C. albicans   between 
macrophages and PMN    s as recent data shows that loss of 
phosphomannan content profoundly reduces the ability of 
macrophages to recognize and ingest   C. albicans   whereas 
loss of   O  -mannan enhances phagocytosis [50]. Loss of 
mannan also results in reduced cytokine production by 
monocytes [2,51]. The percentage of cells of   Candida 
albicans   adhered to and phagocytosed by PMNs was not 
signifi  cantly different in the serotype A and serotype B 
strains. The serotype B strain bears cell wall mannans 
containing   β  1, 2 mannose residues, recently shown to be 
associated with both   N   and   O   mannans [52]. This sug-
gests that   β  1, 2 mannose residues and their putative 
ligand, galectin-3 do not appear to be required for PMN 
binding, phagocytosis or killing. 
  The dependence of the processes of recognition, 
phagocytosis and killing of   C. albicans   by PMN cells 
upon specifi   c receptor-ligand combinations have been 
described previously. Lavigne   et al  . showed that fungal 
cell wall   β  -glucan is important for the recognition of 
adhered   C. albicans   cells, and is able to stimulate the 
antimicrobial respiratory burst in PMNs [53]. The impor-
tance of complement binding to the   C. albicans   cell 
surface was described by Yamamura   et al  ., who showed 
that complement factor C3 was required for   C. albicans  
killing, but not phagocytosis [54]. Work by Taylor   et al . 
links these two studies by showing that murine dectin-1 
(receptor for fungal   β -glucans)-defi  cient neutrophils were 
found to be impaired in their ability to bind un-opsonized 
zymosan particles, resulting in a lowered respiratory 
Fig. 6  Myeloperoxidase and IL-8 quantifi  cation in C. albicans-PMN supernatants. The plot shows MPO and IL-8 production in cell culture supernatant 
following the co-incubation of PMNs (106 cells) with C. albicans strains (3  106 cells) for 30 min at 37°C. MPO and IL-8 concentrations were 
determined by ELISA assay kits. Controls were cell culture supernatant (RPMI only), pre-incubation supernatant (T  0 control), and cell culture 
medium from samples lacking either PMNs (C. albicans only) or C. albicans cells (PMNs only). Plotted values are the mean  standard error of six 
experiments with independent donors, in which each combination was tested in triplicate.© 2011 ISHAM, Medical Mycology, 49, 513–524
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burst [55]. The use of opsonized zymosan particles or   
C. albicans   cells restored binding, however the dectin-1 
defi  cient PMNs remained attenuated in their ability to 
generate the respiratory burst. Dectin-1 defi  ciency resul-
ted in a strong decrease in the ability of PMNs to kill 
unopsonized   C. albicans   cells, however, killing was 
restored with opsonized   C. albicans   [54]. Purifi  ed soluble   
C. albicans   cell wall mannan has also been shown to 
inhibit the interaction between   C. albicans   cells and 
human PMNs, demonstrating the requirement for glycans 
during attachment, and supports the data from our study 
[56]. Studies in mice infected with   C. albicans   showed 
that TLR2 expression on neutrophils was required for 
effi  cient recognition of and chemotaxis towards fungal 
cells. Additionally, neutrophils from TLR2-/- mice were 
shown to be attenuated in their phagocytic activity towards 
  C. albicans   cells as well as expressing lower levels of 
nitric oxide and myeloperoxidase [57]. 
  There were no signifi  cant differences in the levels of 
MPO or IL-8 produced by PMNs in the fi  rst 30 min fol-
lowing contact with the  C. albicans  glycosylation mutants 
tested in our study. Our data confi  rmed that contact with 
fungal cells results in activation-dependent secretion of 
MPO and IL-8 into the culture medium [16,42,58,59]. 
Co-incubation of   C. albicans   cells with cell culture 
supernatant from pre-stimulated PMNs showed that: 
(i) there was no signifi  cant difference between the levels 
of MPO and IL-8 induced by the control strain and the 
  pmr1  Δ   glycosylation-defi   cient mutant; and (ii) there 
was no signifi  cant difference in the percentage of   C. albi-
cans   killed between the control and glycosylation-defi  -
cient strain. These data together suggest that PMNs at 
least in terms of their secretory profi  le do not respond 
specifi  cally to the cell wall glycans of   C. albicans   cells, 
instead generating a broad non-specifi  c cellular response 
to the fungus. 
  This study is the fi  rst to show that ubiquitous cell wall 
  N-   and   O-  linked glycans are involved in the recognition, 
binding and phagocytosis of   C. albicans   by human PMNs. 
Interestingly, studies using human peripheral blood mono-
nuclear cells have found that   N-  linked glycans are pre-
dominantly recognized by the mannose receptor whilst 
  O  -glycans bound TLR4 and that these interactions are 
important for cytokine-stimulating activity by yeast cells [60]. 
Here we show that the production of chemokines and respi-
ratory burst enzymes by PMNs appears not to be dependent 
on cell wall mannosylation. 
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